REQUEST A DEMO
Total
USD $0.00
Search more companies

Zefarm d.o.o. (Bosnia and Herzegovina)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zefarm d.o.o. Profile Updated: October 09, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Zefarm d.o.o Ltd. is a pharmaceutical company. The company is involved in the import, distribution, and wholesale of medicines, pharmaceutical, and sanitary materials. Zefarm d.o.o operates in the Zenica-Doboj Canton and claims to have a 35% share of the pharmaceutical market in the region. The company has business relations with leading pharmaceutical producers and other companies in the region. Zefarm d.o.o's main product is Ge 132, a complex of powerful antioxidants.

Headquarters
Gorazdanska Bb Str.
Zenica; Zenica-Doboj; Postal Code: 72000

Contact Details: Purchase the Zefarm d.o.o. report to view the information.

Website: http://www.zefarm.ba

Basic Information
Total Employees:
Purchase the Zefarm d.o.o. report to view the information.
Outstanding Shares:
Purchase the Zefarm d.o.o. report to view the information.
Registered Capital:
Purchase the Zefarm d.o.o. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
24.9%
Purchase this report to view the information.
17.9%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Zefarm d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BAM. Absolute financial data is included in the purchased report.
Net sales revenue
23.86%
Total operating revenue
23.86%
Operating profit (EBIT)
-68.02%
EBITDA
-54.64%
Net Profit (Loss) for the Period
333.8%
Total assets
32.74%
Total equity
284.95%
Operating Profit Margin (ROS)
-3.85%
Net Profit Margin
12.19%
Return on Equity (ROE)
9.94%
Debt to Equity Ratio
-336.53%
Quick Ratio
0.14%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?